Freedom of Information request on the clinical overview for Nuromol Dual Action Pain Relief 200mg/500mg tablets (FOI 22/812)
Published 21 December 2023
© Crown copyright 2023
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-4-july-2022/freedom-of-information-request-on-the-clinical-overview-for-nuromol-dual-action-pain-relief-200mg500mg-tablets-foi-22812
FOI 22/812
7th July 2022
Dear
Thank you for your email.
Please find attached the response to your FOI request.
Yours sincerely
MHRA Customer Experience Centre